News

Atlanpole Biotherapies joins CEBR Board

The Council of European BioRegions (CEBR) is a network of biotechnology support professionals that support their local biocommunity through direct services including... View Article

Porsolt expands with the acquisition of Fluofarma

Porsolt has acquired Fluofarma, a Bordeaux-based company focused on the provision of cell-based assays and in vitro screening services. The... View Article

IFB-088 (Sephin1) receives orphan drug designation in the European Union for the treatment of Charcot-Marie-Tooth disease

InFlectis BioScience announces that the European Commission has granted orphan drug designation to its drug candidate IFB-088, also known as... View Article

CESTI IHU: Predicting transplant rejection to better anticipate it

The objectives of the programs led by Dr. Sophie Brouard and Pr. Antoine Magnan within the CESTI IHU are to... View Article

Maryvonne Hiance elevated to the rank of Officer of the Legion of Honor

Maryvonne Hiance, Vice President of Atlanpole Biotherapies cluster and manager of Effimune, was given the insignia of Officer of the... View Article

A New member: Gammeo

Gammeo enables the monitoring of all property issues related to a health facility through a simple and intuitive web interface.... View Article

The attraction of CESTI IHU has been the establishment of a professorial position specifically for Pierre-Antoine Gourraud

Professor Pierre-Antoine Gourraud, a recognized specialist in the fields of immunology, genetics and bioinformatics, leaves his position of Associate Professor... View Article